{"text": "fda approves new bmy oral treatment option for ulcerativecolitis uc ibd"}
{"text": "bmy bristol myers fda approved zeposia 0 92 mg for the treatment of adults with moderately to severely active"}
{"text": "bmy the u s food and drug administration approved its oral drug zeposia to treat adults with ulcerative colitis a chronic inflammatory bowel disease congrats"}
{"text": "bmy waiting for buy signal"}
{"text": "bms s zeposia cleared by fda to treat ulcerative colitis bmy"}
{"text": "bmy u s food and drug administration approves bristol myers squibbs zeposia ozanimod an oral treatment for adults with moderately to severely active ulcerative colitis1 business wire"}
